MannKind Corp
MNKD
#4917
Rank
C$2.43 B
Marketcap
C$7.93
Share price
-0.53%
Change (1 day)
-15.97%
Change (1 year)

Earnings for MannKind Corp (MNKD)

Earnings in 2025 (TTM): C$43.82 Million

According to MannKind Corp's latest financial reports the company's current earnings are C$0.31 Billion. In 2024 the company made an earning of C$42.6 Million, an increase over its 2023 earnings that were of -C$14.49 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for MannKind Corp from 2004 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) C$43.82 M2.87%
2024 C$42.6 M-394.09%
2023 -C$14.49 Million-88.13%
2022 -C$0.13 Billion8%
2021 -C$0.12 Billion40.84%
2020 -C$80.21 Million10.7%
2019 -C$72.46 Million-40.16%
2018 -C$0.13 Billion-26.04%
2017 -C$0.17 Billion-193.33%
2016 C$0.17 B-134.11%
2015 -C$0.52 Billion85.72%
2014 -C$0.28 Billion3.6%
2013 -C$0.27 Billion12.79%
2012 -C$0.24 Billion5.58%
2011 -C$0.23 Billion-5.72%
2010 -C$0.24 Billion-22.51%
2009 -C$0.31 Billion-27.37%
2008 -C$0.43 Billion3.36%
2007 -C$0.41 Billion27.18%
2006 -C$0.33 Billion101.63%
2005 -C$0.16 Billion50.46%
2004 -C$0.11 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Halozyme Therapeutics
HALO
C$1.04 B 2,323.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
C$29.10 B 67,618.55%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Merck
MRK
C$32.23 B 74,908.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
C$31.41 B 73,003.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-C$0.16 Billion-469.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
C$16.54 B 38,401.77%๐Ÿ‡บ๐Ÿ‡ธ USA